Skip to content
Screener

Celldex Therapeutics CLDX Business Segments — Facility Cost

Similar metrics at other companies

SES AI logo
SESSingle Reportable — Costs Of Facility
$1.42M-8.5%
uniQure logo
QURESingle Reportable — Facility Expenses
$1.44M-15.7%
Cracker Barrel Old Country Store logo
CBRLSingle Reportable — Cost Maintenance
$30.03M+1.9%
ALO
ALOVSingle Reportable — Deferred Costs
$261.48K
Ur-Energy logo
URGSingle Reportable — Development Costs
$14.95M+53.4%
Vertex, Inc. logo
VERXSingle Reportable — Transaction Costs
-$5.98M-125%

Other financials

Income statement

See full
Revenue$22.0K-97.0%
Operating income-$80.6M-26.3%
Net income-$73.5M-29.9%
EPS (diluted)-$0.94-10.6%

Balance sheet

See full
Cash & equivalents$47.5M+106%
Total debt$4.9M+61.8%
Total equity$714.6M+9.0%
Total assets$782.3M+13.0%

Cash flow

See full
Operating cash flow-$57.4M-30.5%
CapEx$3.2M+337%
Free cash flow-$60.6M-35.4%

Valuation

See full
Market cap$3.26B+129%
Enterprise value$3.22B+129%
P/S20,646.4×+20,401×

Profitability

See full
Operating margin-206,220.3%-210,440pp
Net margin-190,220.9%-193,797pp
FCF margin-153,231%-156,630pp

Returns & leverage

See full
Return on equity-43.9%+70.0pp
Debt / equity0.0×
Current ratio11.8×-7.8×

Where this comes from

Reported directly by Celldex Therapeutics in its filing.

Tagged under the XBRL concept cldx:FacilityCost.

The source filing: Celldex Therapeutics’s 10-K, filed February 25, 2026.

Filed
Feb 25, 2026, 4:06 PM EST
Fiscal year
FY2025
Accession
0001104659-26-019652
Line itemYear Ended / December 31, 2025Year Ended / December 31, 2024Year Ended / December 31, 2023
Personnel$57,204$51,906$40,121
Laboratory Supplies5,9975,6115,358
Facility5,3015,0944,970
Product Development (b)161,09690,60459,319
Other Expenses (c)15,47610,3358,243
Total R&D Expense$245,074$163,550$118,011

Item 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

FAQ

What is Celldex Therapeutics's business segments — facility cost?
Celldex Therapeutics (CLDX) reported business segments — facility cost of $1.33M in Q4 2025.
How has Celldex Therapeutics's business segments — facility cost changed year-over-year?
Celldex Therapeutics's business segments — facility cost increased by 4.1% year-over-year, from $1.27M to $1.33M.
What is the long-term trend for Celldex Therapeutics's business segments — facility cost?
Over 3 years (2022 to 2025), Celldex Therapeutics's business segments — facility cost has grown at a 3.6% compound annual growth rate (CAGR), from $4.76M to $5.3M.
What does business segments — facility cost mean?
This metric tracks the recurring costs associated with the physical facilities used for research and development operations within the primary business segment. It encompasses lease obligations, property taxes, and facility-related maintenance expenses. This metric is useful for evaluating the efficiency of the company's physical asset utilization in supporting its scientific goals.

Ask your AI about Celldex Therapeutics's business segments — facility cost.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude